KURSSIT JA MARKKINAT / UUTISET

Uutisarkisto

Pvm
Lähde
Otsikko
30.03 19:30 GlobeNewswire
Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab in Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma
30.03   19:30    GlobeNewswire Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab in Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma
30.03 19:30 GlobeNewswire
Leasinvest Real Estate SCA: Update Covid-19-impact - Annual financial report 2019
30.03   19:30    GlobeNewswire Leasinvest Real Estate SCA: Update Covid-19-impact - Annual financial report 2019
30.03 19:21 GlobeNewswire
Transaction in Own Shares
30.03   19:21    GlobeNewswire Transaction in Own Shares
30.03 19:05 GlobeNewswire
L'Oréal: News release: "Annual General Meeting Postponed - 2020 Outlook"
30.03   19:05    GlobeNewswire L'Oréal: News release: "Annual General Meeting Postponed - 2020 Outlook"
30.03 19:00 GlobeNewswire
IGE+XAO: Availability of the buy-back program for IGE+XAO Group
30.03   19:00    GlobeNewswire IGE+XAO: Availability of the buy-back program for IGE+XAO Group
30.03 19:00 GlobeNewswire
IGE+XAO: Availability of 2019 report on corporate governance for IGE+XAO Group
30.03   19:00    GlobeNewswire IGE+XAO: Availability of 2019 report on corporate governance for IGE+XAO Group
30.03 19:00 GlobeNewswire
IGE+XAO : Availability of 2019 financial report for IGE+XAO Group
30.03   19:00    GlobeNewswire IGE+XAO : Availability of 2019 financial report for IGE+XAO Group
30.03 19:00 GlobeNewswire
EXEL Industries: Situation related to the Covid-19 virus
30.03   19:00    GlobeNewswire EXEL Industries: Situation related to the Covid-19 virus
30.03 19:00 GlobeNewswire
EssilorLuxottica: Laurent Vacherot retires & Paul du Saillant to step in at EssilorLuxottica
30.03   19:00    GlobeNewswire EssilorLuxottica: Laurent Vacherot retires & Paul du Saillant to step in at EssilorLuxottica
30.03 18:46 GlobeNewswire
Update impact Covid-19
30.03   18:46    GlobeNewswire Update impact Covid-19
30.03 18:46 GlobeNewswire
Update on Solvay Extraordinary General meeting of April 3, 2020
30.03   18:46    GlobeNewswire Update on Solvay Extraordinary General meeting of April 3, 2020
30.03 18:45 GlobeNewswire
Nexans : Disclosure of trading in own shares from March 18, 2020 to March 20, 2020
30.03   18:45    GlobeNewswire Nexans : Disclosure of trading in own shares from March 18, 2020 to March 20, 2020
30.03 18:45 GlobeNewswire
Quadient: 2019 full-year results and Q4 2019 sales
30.03   18:45    GlobeNewswire Quadient: 2019 full-year results and Q4 2019 sales
30.03 18:45 GlobeNewswire
Information regarding the measures adopted by McPhy within the context of the Covid-19 pandemic
30.03   18:45    GlobeNewswire Information regarding the measures adopted by McPhy within the context of the Covid-19 pandemic
30.03 18:45 GlobeNewswire
Euronext statement in relation to Bolsas y Mercados Españoles (“BME”)
30.03   18:45    GlobeNewswire Euronext statement in relation to Bolsas y Mercados Españoles (“BME”)
30.03 18:45 GlobeNewswire
Rovio Entertainment Oyj: Omien osakkeiden hankinta 30.03.2020
30.03   18:45    GlobeNewswire Rovio Entertainment Oyj: Omien osakkeiden hankinta 30.03.2020
30.03 18:45 GlobeNewswire
Rovio Entertainment Corporation: Repurchase of own shares on 30 March 2020
30.03   18:45    GlobeNewswire Rovio Entertainment Corporation: Repurchase of own shares on 30 March 2020
30.03 18:45 GlobeNewswire
Ageas and BlackRock: Transparency notification
30.03   18:45    GlobeNewswire Ageas and BlackRock: Transparency notification
30.03 18:44 GlobeNewswire
Derivatives - New Strikes Stock Products 64/20
30.03   18:44    GlobeNewswire Derivatives - New Strikes Stock Products 64/20
30.03 18:40 GlobeNewswire
Ageas reports on the progress of share buy-back programme
30.03   18:40    GlobeNewswire Ageas reports on the progress of share buy-back programme
30.03 18:34 GlobeNewswire
Hexagon Composites ASA: Mandatory notification of trade
30.03   18:34    GlobeNewswire Hexagon Composites ASA: Mandatory notification of trade
30.03 18:30 GlobeNewswire
Investors House Oyj: OMIEN OSAKKEIDEN HANKINTA 30.3.2020
30.03   18:30    GlobeNewswire Investors House Oyj: OMIEN OSAKKEIDEN HANKINTA 30.3.2020
30.03 18:30 GlobeNewswire
SCANFIL OYJ: OMIEN OSAKKEIDEN HANKINTA 30.03.2020
30.03   18:30    GlobeNewswire SCANFIL OYJ: OMIEN OSAKKEIDEN HANKINTA 30.03.2020
30.03 18:30 GlobeNewswire
Scanfil Plc: Share Repurchase 30.03.2020
30.03   18:30    GlobeNewswire Scanfil Plc: Share Repurchase 30.03.2020
30.03 18:30 GlobeNewswire
GOFORE OYJ: OMIEN OSAKKEIDEN HANKINTA 30.03.2020
30.03   18:30    GlobeNewswire GOFORE OYJ: OMIEN OSAKKEIDEN HANKINTA 30.03.2020
30.03 18:30 GlobeNewswire
GOFORE PLC: SHARE REPURCHASE 30.03.2020
30.03   18:30    GlobeNewswire GOFORE PLC: SHARE REPURCHASE 30.03.2020
30.03 18:29 GlobeNewswire
Subsea 7 share repurchase
30.03   18:29    GlobeNewswire Subsea 7 share repurchase
30.03 18:25 GlobeNewswire
Notification on transactions on the Issuer's securities
30.03   18:25    GlobeNewswire Notification on transactions on the Issuer's securities
30.03 18:15 GlobeNewswire
Nubeqa®-lääkkeelle (darolutamidi) myyntilupa EU:ssa etäpesäkkeettömän, hormonaaliselle hoidolle vastustuskykyisen eturauhassyövän uutena hoitona
30.03   18:15    GlobeNewswire Nubeqa®-lääkkeelle (darolutamidi) myyntilupa EU:ssa etäpesäkkeettömän, hormonaaliselle hoidolle vastustuskykyisen eturauhassyövän uutena hoitona
30.03 18:15 GlobeNewswire
Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
30.03   18:15    GlobeNewswire Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
30.03 18:13 GlobeNewswire
Resolutions from Tryg A/S’ annual general meeting 2020
30.03   18:13    GlobeNewswire Resolutions from Tryg A/S’ annual general meeting 2020
30.03 18:07 GlobeNewswire
Fixing of coupon rate - Danmarks Skibskredit A/S
30.03   18:07    GlobeNewswire Fixing of coupon rate - Danmarks Skibskredit A/S
30.03 18:03 GlobeNewswire
Net Asset Value(s)
30.03   18:03    GlobeNewswire Net Asset Value(s)
30.03 18:00 GlobeNewswire
Regarding Allocation of Liquefied Natural Gas Terminal Capacities
30.03   18:00    GlobeNewswire Regarding Allocation of Liquefied Natural Gas Terminal Capacities
30.03 18:00 GlobeNewswire
Kambi Group plc publishes 2019 Annual Report and Accounts
30.03   18:00    GlobeNewswire Kambi Group plc publishes 2019 Annual Report and Accounts
30.03 17:52 GlobeNewswire
Form 8.3 - [Willis Towers Watson Plc]
30.03   17:52    GlobeNewswire Form 8.3 - [Willis Towers Watson Plc]
30.03 17:48 GlobeNewswire
Form 8.3 - [Aon Plc]
30.03   17:48    GlobeNewswire Form 8.3 - [Aon Plc]
30.03 17:45 GlobeNewswire
Form 8.3 - [Allergan Plc]
30.03   17:45    GlobeNewswire Form 8.3 - [Allergan Plc]
30.03 17:45 GlobeNewswire
CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER
30.03   17:45    GlobeNewswire CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER
30.03 17:43 GlobeNewswire
Announcement of the Management's or Related parties' trading with SP Group shares
30.03   17:43    GlobeNewswire Announcement of the Management's or Related parties' trading with SP Group shares
30.03 17:40 GlobeNewswire
Form 8.3 - [Abbvie. Inc]
30.03   17:40    GlobeNewswire Form 8.3 - [Abbvie. Inc]
30.03 17:20 GlobeNewswire
Middlefield Canadian Income PCC: Net Asset Value(s)
30.03   17:20    GlobeNewswire Middlefield Canadian Income PCC: Net Asset Value(s)
30.03 17:20 GlobeNewswire
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
30.03   17:20    GlobeNewswire Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
30.03 17:06 GlobeNewswire
CORRECTION: Extraordinary Shareholders' Meeting of JSC SAKRET HOLDINGS (update)
30.03   17:06    GlobeNewswire CORRECTION: Extraordinary Shareholders' Meeting of JSC SAKRET HOLDINGS (update)
30.03 17:05 GlobeNewswire
Invesco ltd: Form 8.3 - Willis Towers Watson PLC
30.03   17:05    GlobeNewswire Invesco ltd: Form 8.3 - Willis Towers Watson PLC
30.03 17:05 GlobeNewswire
Kitron: Publishing of Annual Report for 2019
30.03   17:05    GlobeNewswire Kitron: Publishing of Annual Report for 2019
30.03 17:03 GlobeNewswire
TRANSFER OF WARRANTS TO THE EXTENDED TRADING MARKET SEGMENT
30.03   17:03    GlobeNewswire TRANSFER OF WARRANTS TO THE EXTENDED TRADING MARKET SEGMENT
30.03 17:02 GlobeNewswire
LISTING OF TURBO WARRANTS ISSUED BY MORGAN STANLEY & CO. INTERNATIONAL PLC
30.03   17:02    GlobeNewswire LISTING OF TURBO WARRANTS ISSUED BY MORGAN STANLEY & CO. INTERNATIONAL PLC
30.03 17:00 GlobeNewswire
Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High Bleeding Risk Stent Patients Beats Performance Goal
30.03   17:00    GlobeNewswire Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High Bleeding Risk Stent Patients Beats Performance Goal
30.03 16:59 GlobeNewswire
ISTING OF MINI FUTURES ISSUED BY MORGAN STANLEY & CO. INTERNATIONAL PLC
30.03   16:59    GlobeNewswire ISTING OF MINI FUTURES ISSUED BY MORGAN STANLEY & CO. INTERNATIONAL PLC
Powered by FactSet and Implemented by NFS.